nadroparin calcium aspen forte 11,400 i.u. anti-xa/0.6ml solution for injection in a pre-filled syringe.
aspen pharma trading limited - nadroparin calcium - solution for injection in pre-filled syringe - 11,400 i.u. anti-xa/0.6 millilitre(s) - heparin group; nadroparin
nadroparin calcium aspen forte 15,200 i.u. anti-xa/0.8ml solution for injection in a pre-filled syringe.
aspen pharma trading limited - nadroparin calcium - solution for injection in pre-filled syringe - 15,200 i.u.anti-xa/0.8 millilitre(s) - heparin group; nadroparin
nadroparin calcium aspen forte 19,000 i.u. anti-xa/ml solution for injection in a pre-filled syringe
aspen pharma trading limited - nadroparin calcium - solution for injection in pre-filled syringe - 19,000 international unit(s)/millilitre - heparin group; nadroparin
nadroparin calcium aspen forte 15,200 i.u. anti-xa/0.8ml solution for injection in a pre-filled syringe.
mylan ire healthcare limited - nadroparin calcium - solution for injection in pre-filled syringe - 15,200 i.u.anti-xa/0.8 millilitre(s) - heparin group; nadroparin
nadroparin calcium aspen forte 11,400 i.u. anti-xa/0.6ml solution for injection in a pre-filled syringe.
mylan ire healthcare limited - nadroparin calcium - solution for injection in pre-filled syringe - 11,400 i.u. anti-xa/0.6 millilitre(s) - heparin group; nadroparin
nadroparin calcium aspen forte 19,000 i.u. anti-xa/ml solution for injection in a pre-filled syringe
mylan ire healthcare limited - nadroparin calcium - solution for injection in pre-filled syringe - 19,000 international unit(s)/millilitre - heparin group; nadroparin
microlite 100/20 microgram tablets
bayer limited - ethinylestradiol; levonorgestrel - tablet - 100/20 microgram(s) - progestogens and estrogens, fixed combinations; levonorgestrel and ethinylestradiol
sondelbay (teriparatide) 20 micrograms 80 microliters solution for injection in pre-filled pen
accord healthcare sdn.bhd. - teriparatide -
microliteasyfill
smacco flo (t) limited, tanzania - pipette -
venclexta 10 mg tablets
abbvie biopharmaceuticals ltd, israel - venetoclax - film coated tablets - venetoclax 10 mg - venetoclax - chronic lymphocytic leukemia/small lymphocytic lymphomavenclexta in combination with rituximab or as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukaemia (cll) or small lymphocytic lymphoma (sll), who have received at least one prior therapy.venclexta in combination with obinutuzumab is indicated for the treatment of patients with previously untreated chronic lymphocytic leukaemia (cll) or small lymphocytic lymphoma (sll).acute myeloid leukemiavenclexta in combination with a hypomethylating agent or in combination with low dose cytarabine is indicated for newly diagnosed patients with acute myeloid leukemia (aml) who are ineligible for intensive chemotherapy.